GoAI
Get started
Omada Health logo

Omada Health

OMDA

NASDAQHealthcareMedical - Healthcare Information Services

Open in GoAI

Previous close

$24.08

+$0.19 · +0.80%

Aug 24, 4:00 PM ET

After-hours

$23.72

−$0.36 · -1.50%

Aug 24, 7:36 PM ET

OMDA company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

80

Undervalued

Momentum

65

Gaining

Sentiment

45

Mixed

Risk resilience

50

Elevated Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Omada Health is an American virtual health company that delivers evidence-based digital programs designed to manage common chronic ailments, including cardiometabolic, musculoskeletal, and behavioral health conditions, offering continuous support that bridges the gap between in-person medical appointments.

Industry
Medical - Healthcare Information Services
Sector
Healthcare
Headquarters
US
CEO
Sean Duffy
Listed since
Jun 6, 2025
Employees
946

Market position

Day range

Current $24.08

52-week range

Current $24.08

Open
$23.94
Previous close
$23.89
Volume
942.39K
0.76× average
Average volume
1.24M
Average daily volume
Market cap
1.43B USD
Beta
1.72
Market reference 1
50-day average
$21.6396
+11.28% above average
200-day average
$16.8706
+42.73% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
699.97M USD
P/E (TTM)
354.64×
P/B (TTM)
5.69×
P/S (TTM)
4.62×
EV / EBITDA
-147.27×
Earnings yield
-1.39%
Free cash flow yield
1.84%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
68.19%
Operating margin
-0.15%
Net margin
1.39%
Return on equity
-5.56%
Return on assets
-4.18%
Return on invested capital
-5.21%

Financial health

Debt / equity
0×
Current ratio
3.6×
Altman Z-score
11.47
Piotroski F-score
7 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends80%22%-37%-96%Gross margin, FY2022: 47.98%Gross margin, FY2023: 56.99%Gross margin, FY2024: 60.59%Gross margin, FY2025: 65.69%Operating margin, FY2022: -81.12%Operating margin, FY2023: -53.75%Operating margin, FY2024: -25.71%Operating margin, FY2025: -4.60%Net margin, FY2022: -81.31%Net margin, FY2023: -54.98%Net margin, FY2024: -27.76%Net margin, FY2025: -4.91%FY2022FY2023FY2024FY2025
Gross margin FY2022 47.98%. Gross margin FY2023 56.99%. Gross margin FY2024 60.59%. Gross margin FY2025 65.69%. Operating margin FY2022 -81.12%. Operating margin FY2023 -53.75%. Operating margin FY2024 -25.71%. Operating margin FY2025 -4.60%. Net margin FY2022 -81.31%. Net margin FY2023 -54.98%. Net margin FY2024 -27.76%. Net margin FY2025 -4.91%.

Income trends

Revenue

260.21M USD+53.24%

Operating income

−11.97M USD+72.58%

Net income

−12.78M USD+72.89%
Income trends across reported periods293.48M USD160.39M USD27.3M USD−105.79M USDRevenue, FY2022: 89.19M USDRevenue, FY2023: 122.78M USDRevenue, FY2024: 169.8M USDRevenue, FY2025: 260.21M USDOperating income, FY2022: −72.35M USDOperating income, FY2023: −66M USDOperating income, FY2024: −43.65M USDOperating income, FY2025: −11.97M USDNet income, FY2022: −72.52M USDNet income, FY2023: −67.51M USDNet income, FY2024: −47.14M USDNet income, FY2025: −12.78M USDFY2022FY2023FY2024FY2025
Revenue FY2022 89.19M USD. Revenue FY2023 122.78M USD. Revenue FY2024 169.8M USD. Revenue FY2025 260.21M USD. Operating income FY2022 −72.35M USD. Operating income FY2023 −66M USD. Operating income FY2024 −43.65M USD. Operating income FY2025 −11.97M USD. Net income FY2022 −72.52M USD. Net income FY2023 −67.51M USD. Net income FY2024 −47.14M USD. Net income FY2025 −12.78M USD.
Metric (USD)FY2025FY2024FY2023FY2022
Revenue260.21M USD169.8M USD122.78M USD89.19M USD
Cost of goods sold89.27M USD66.92M USD52.81M USD46.39M USD
Gross profit170.94M USD102.88M USD69.97M USD42.79M USD
Research and development40.68M USD35.92M USD33.74M USD26.17M USD
Selling, general, and administrative142.23M USD110.61M USD102.23M USD88.97M USD
Operating expenses182.91M USD146.53M USD135.97M USD115.14M USD
Interest income5.31M USD805K USD5.78M USD2.2M USD
Interest expense2.53M USD4.51M USD4.71M USD4.2M USD
Depreciation and amortization5.49M USD4.8M USD4.45M USD4.33M USD
Operating income−11.97M USD−43.65M USD−66M USD−72.35M USD
Net income−12.78M USD−47.14M USD−67.51M USD−72.52M USD

Company facts updated Aug 25, 2026.

Earnings

EPS beat rate
83%
5 beats, 1 miss, 0 met estimates
Average EPS surprise
+104.52%
6 comparable reports
Latest EPS result
0.15
Estimate 0.06 · Beat by 141.16%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.190.07-0.05-0.17Q2 '25MissQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q2 2025, reported May 9, 2025: actual -0.13, estimate -0.118, surprise -9.86%, Miss. Q3 2025, reported Aug 7, 2025: actual -0.09, estimate -0.1, surprise +10.00%, Beat. Q4 2025, reported Nov 6, 2025: actual -0.06, estimate -0.1, surprise +40.00%, Beat. Q1 2026, reported Mar 5, 2026: actual 0.13, estimate 0.03, surprise +333.33%, Beat. Q2 2026, reported May 7, 2026: actual 0.01, estimate -0.08, surprise +112.50%, Beat. Q3 2026, reported Aug 6, 2026: actual 0.15, estimate 0.062, surprise +141.16%, Beat. Q4 2026, reported Nov 5, 2026: actual —, estimate 0.09, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates91.35M78.05M64.75M51.45MQ2 '25MissQ3 '25BeatQ4 '25MissQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q2 2025, reported May 9, 2025: actual 54.96M USD, estimate 55.33M USD, surprise -0.66%, Miss. Q3 2025, reported Aug 7, 2025: actual 61.37M USD, estimate 55.33M USD, surprise +10.92%, Beat. Q4 2025, reported Nov 6, 2025: actual 68.03M USD, estimate 69.04M USD, surprise -1.46%, Miss. Q1 2026, reported Mar 5, 2026: actual 75.85M USD, estimate 70.21M USD, surprise +8.03%, Beat. Q2 2026, reported May 7, 2026: actual 78.05M USD, estimate 74.09M USD, surprise +5.34%, Beat. Q3 2026, reported Aug 6, 2026: actual 87.84M USD, estimate 80.04M USD, surprise +9.74%, Beat. Q4 2026, reported Nov 5, 2026: actual —, estimate 85.47M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$25.63

6.44% upside
Past 12 months12-month forecastHigh $35.00Average $25.63Low $18.00

Rating distribution

12 ratings
Strong buy00%
Buy1083%
Hold217%
Sell00%
Strong sell00%

Recent analyst actions

12 institutions
BairdmaintainNeutral
BTIGmaintainBuy
Wells FargomaintainEqual Weight

OMDA news

seekingalpha.com

Omada Health: Q2 Shows More Evidence Of Growth Converting Into Earnings

Omada Health (OMDA) delivered strong Q2 results, with 43% revenue growth, margin expansion, and positive adj. EBITDA, reinforcing my buy rating. OMDA's product expansion, especially in diabetes and hypertension, is…

Read source
marketbeat.com

Omada Health Touts Record Q2 as GLP-1 Demand Fuels Growth Strategy

Omada Health NASDAQ: OMDA highlighted record second-quarter revenue and margin performance at the Canaccord Genuity Growth Conference, while outlining its strategy to expand across cardiometabolic conditions, deepen…

Read source
zacks.com

Omada Health, Inc. (OMDA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Omada Health, Inc. (OMDA) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates…

Read source
seekingalpha.com

Omada Health, Inc. (OMDA) Q2 2026 Earnings Call Transcript

Omada Health, Inc. (OMDA) Q2 2026 Earnings Call Transcript

Read source
marketbeat.com

Omada Health Q2 Earnings Call Highlights

Omada Health NASDAQ: OMDA reported record second-quarter results for 2026, citing broad-based growth across its cardiometabolic programs, expanding channel partnerships and lower costs to serve members. The company also…

Read source
zacks.com

Omada Health, Inc. (OMDA) Q2 Earnings and Revenues Top Estimates

Omada Health, Inc. (OMDA) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to a loss of $0.09 per share a year ago.

Read source

OMDA peers

Amgen Inc. logo

AMGN

Amgen Inc.

$443.84

+1.03%

Gilead Sciences, Inc. logo

GILD

Gilead Sciences, Inc.

$146.74

+0.42%

Vertex Pharmaceuticals Incorporated logo

VRTX

Vertex Pharmaceuticals Incorporated

$547.59

-0.08%

Intuitive Surgical, Inc. logo

ISRG

Intuitive Surgical, Inc.

$373.57

-1.38%

Sanofi logo

SNY

Sanofi

$45.69

-0.35%

Regeneron Pharmaceuticals, Inc. logo

REGN

Regeneron Pharmaceuticals, Inc.

$828.5

-0.66%

ETFs holding OMDA

Funds reporting this stock among their holdings, ordered by reported position size.

Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
35.64M
Weight
0.00%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$377.07-0.31%
iShares Russell 2000 ETF logoiShares Russell 2000 ETFIWM
Market value
21.76M
Weight
0.03%
AUM
80.54B USD
Expense ratio
0.19%
Price / 1D
$297.97-0.66%
iShares Russell 2000 Growth ETF logoiShares Russell 2000 Growth ETFIWO
Market value
7.98M
Weight
0.05%
AUM
14.98B USD
Expense ratio
0.24%
Price / 1D
$383.16-1.09%
Vanguard Russell 2000 ETF logoVanguard Russell 2000 ETFVTWO
Market value
3.96M
Weight
0.02%
AUM
17.4B USD
Expense ratio
0.06%
Price / 1D
$120.47-0.64%
Fidelity Enhanced Small Cap ETF logoFidelity Enhanced Small Cap ETFFESM
Market value
3.45M
Weight
0.05%
AUM
6.03B USD
Expense ratio
0.28%
Price / 1D
$47.62-0.67%
Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
1.94M
Weight
0.00%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$243.43-0.86%
CapForce IBD 50 ETF logoCapForce IBD 50 ETFFFTY
Market value
1.48M
Weight
1.95%
AUM
89.4M USD
Expense ratio
0.80%
Price / 1D
$36.855-0.15%
Vanguard Health Care ETF logoVanguard Health Care ETFVHT
Market value
1.15M
Weight
0.01%
AUM
20.9B USD
Expense ratio
0.09%
Price / 1D
$327.49-0.06%

Continue in GoAI

Research OMDA

research.disclaimer